Literature DB >> 16709695

Assessment of cardiac risk before non-cardiac surgery: brain natriuretic peptide in 1590 patients.

J Dernellis1, M Panaretou.   

Abstract

OBJECTIVE: To evaluate the predictive value of brain natriuretic peptide (BNP) for assessment of cardiac risk before non-cardiac surgery.
METHODS: Consecutively treated patients (947 men, 643 women) whose BNP was measured before non-cardiac surgery were studied. Clinical and ECG variables were evaluated to identify predictors of postoperative cardiac events.
RESULTS: Events occurred in 6% of patients: 21 cardiac deaths, 20 non-fatal myocardial infarctions, 41 episodes of pulmonary oedema and 14 patients with ventricular tachycardia. All of these patients had raised plasma BNP concentrations (best cut-off point 189 pg/ml). The only independent predictor of postoperative events was BNP (odds ratio 34.52, 95% confidence interval (CI) 17.08 to 68.62, p < 0.0001). Clinical variables of Goldman's multifactorial index identified 18% of patients in class I, 40% in class II, 24% in class III and 18% in class IV preoperatively; postoperative event rates were 2%, 3%, 7% and 14%, respectively. BNP identified 60% of patients as having zero risk (BNP 0-100 pg/ml), 22% low risk (101-200 pg/ml), 14% intermediate risk (201-300 pg/ml) and 4% high risk (> 300 pg/ml); postoperative event rates were 0%, 5%, 12% and 81%, respectively.
CONCLUSIONS: In this population of patients evaluated before non-cardiac surgery, BNP is an independent predictor of postoperative cardiac events. BNP > 189 pg/ml identified patients at highest risk.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16709695      PMCID: PMC1861227          DOI: 10.1136/hrt.2005.085530

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  22 in total

1.  ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery).

Authors:  Kim A Eagle; Peter B Berger; Hugh Calkins; Bernard R Chaitman; Gordon A Ewy; Kirsten E Fleischmann; Lee A Fleisher; James B Froehlich; Richard J Gusberg; Jeffrey A Leppo; Thomas Ryan; Robert C Schlant; William L Winters; Raymond J Gibbons; Elliott M Antman; Joseph S Alpert; David P Faxon; Valentin Fuster; Gabriel Gregoratos; Alice K Jacobs; Loren F Hiratzka; Richard O Russell; Sidney C Smith
Journal:  J Am Coll Cardiol       Date:  2002-02-06       Impact factor: 24.094

2.  Multifactorial index of cardiac risk in noncardiac surgical procedures.

Authors:  L Goldman; D L Caldera; S R Nussbaum; F S Southwick; D Krogstad; B Murray; D S Burke; T A O'Malley; A H Goroll; C H Caplan; J Nolan; B Carabello; E E Slater
Journal:  N Engl J Med       Date:  1977-10-20       Impact factor: 91.245

3.  Assessment of cardiac risk in surgical patients.

Authors:  A A Gage; J N Bhayana; V Balu; N Hook
Journal:  Arch Surg       Date:  1977-12

4.  The limited reliability of physical signs for estimating hemodynamics in chronic heart failure.

Authors:  L W Stevenson; J K Perloff
Journal:  JAMA       Date:  1989-02-10       Impact factor: 56.272

5.  Preoperative plasma N-terminal pro-brain natriuretic peptide as a marker of cardiac risk in patients undergoing elective non-cardiac surgery.

Authors:  H-M Yeh; H-P Lau; J-M Lin; W-Z Sun; M-J Wang; L-P Lai
Journal:  Br J Surg       Date:  2005-08       Impact factor: 6.939

Review 6.  The role of preoperative radionuclide ejection fraction in direct abdominal aortic aneurysm repair.

Authors:  A Kazmers; M D Cerqueira; R E Zierler
Journal:  J Vasc Surg       Date:  1988-08       Impact factor: 4.268

7.  Cardiac prognosis in noncardiac geriatric surgery.

Authors:  M C Gerson; J M Hurst; V S Hertzberg; P A Doogan; M B Cochran; S P Lim; N McCall; R J Adolph
Journal:  Ann Intern Med       Date:  1985-12       Impact factor: 25.391

8.  B-type natriuretic peptide and ischemia in patients with stable coronary disease: data from the Heart and Soul study.

Authors:  Kirsten Bibbins-Domingo; Maria Ansari; Nelson B Schiller; Barry Massie; Mary A Whooley
Journal:  Circulation       Date:  2003-12-08       Impact factor: 29.690

Review 9.  Cardiac risks and complications of noncardiac surgery.

Authors:  L Goldman
Journal:  Ann Intern Med       Date:  1983-04       Impact factor: 25.391

10.  Preliminary evaluation of the AxSYM B-type natriuretic peptide (BNP) assay and comparison with the ADVIA Centaur BNP assay.

Authors:  Thomas Mueller; Alfons Gegenhuber; Werner Poelz; Meinhard Haltmayer
Journal:  Clin Chem       Date:  2004-06       Impact factor: 8.327

View more
  16 in total

Review 1.  Sleep apnea in total joint arthroplasty patients and the role for cardiac biomarkers for risk stratification: an exploration of feasibility.

Authors:  M Melanie Lyons; Nitin Y Bhatt; Elizabeth Kneeland-Szanto; Brendan T Keenan; Joanne Pechar; Branden Stearns; Nabil M Elkassabany; Stavros G Memtsoudis; Allan I Pack; Indira Gurubhagavatula
Journal:  Biomark Med       Date:  2016       Impact factor: 2.851

2.  Preliminary Development of a DNA Aptamer-Magnetic Bead Capture Electrochemiluminescence Sandwich Assay for Brain Natriuretic Peptide.

Authors:  John G Bruno; Alicia M Richarte; Taylor Phillips
Journal:  Microchem J       Date:  2014-07-01       Impact factor: 4.821

3.  Volatile anaesthetics and cardiac protection in abdominal surgery.

Authors:  Jasminka Kopić
Journal:  Wien Klin Wochenschr       Date:  2015-07-10       Impact factor: 1.704

Review 4.  Preoperative cardiac risk assessment for noncardiac surgery in patients with heart failure.

Authors:  Jenica Upshaw; Michael S Kiernan
Journal:  Curr Heart Fail Rep       Date:  2013-06

5.  Natriuretic Peptides and Assessment of Cardiovascular Disease Risk in Asymptomatic Persons.

Authors:  Lori B Daniels
Journal:  Curr Cardiovasc Risk Rep       Date:  2010-02-17

6.  Preoperative B-type natriuretic peptide is as independent predictor of ventricular dysfunction and mortality after primary coronary artery bypass grafting.

Authors:  Amanda A Fox; Stanton K Shernan; Charles D Collard; Kuang-Yu Liu; Sary F Aranki; Stacia M DeSantis; Petr Jarolim; Simon C Body
Journal:  J Thorac Cardiovasc Surg       Date:  2008-08       Impact factor: 5.209

7.  Plasma N-terminal pro-B-type natriuretic peptide is predictive of perioperative cardiac events in patients undergoing vascular surgery.

Authors:  Ji Hyun Yang; Jin Ho Choi; Young-Wook Ki; Dong Ik Kim; Duk-Kyung Kim; Jeong Rang Park; Jae K Oh; Seung-Hyuk Choi
Journal:  Korean J Intern Med       Date:  2012-09-01       Impact factor: 2.884

8.  Postoperative B-type natriuretic Peptide levels associated with prolonged hospitalization in hypertensive patients after non-cardiac surgery.

Authors:  Jae Hong Park; Gil Ja Shin; Jae In Ryu; Wook Bum Pyun
Journal:  Korean Circ J       Date:  2012-08-31       Impact factor: 3.243

9.  Utility of B-type natriuretic Peptide for predicting perioperative cardiovascular events in patients without history of cardiovascular disease undergoing major non-cardiac surgery.

Authors:  Sung Eun Kim; Dae-Gyun Park; Jun Hee Lee; Kyoo Rok Han; Dong Jin Oh
Journal:  Korean Circ J       Date:  2011-01-31       Impact factor: 3.243

10.  Prognostic value of plasma N-terminal pro-B-type natriuretic peptide concentration in patients with normal and impaired left ventricular systolic function undergoing surgery for abdominal aortic aneurysm.

Authors:  Marek Waliszek; Agnieszka Waliszek-Iwanicka; Tomasz Grycewicz; Piotr Jurowski; Maciej Banach; Jacek Rysz; Aleksander Goch
Journal:  Arch Med Sci       Date:  2011-09-02       Impact factor: 3.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.